EcoDrugPlus

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSPMAG00000003363
Gene Symbol: ABCB1
2 Cross references
164 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 4

Ensembl ID : ENSPMAG00000008154
Gene Symbol: ATP1A1A.4
1 Cross references
324 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSPMAG00000003096
Gene Symbol: ATR
1 Cross references
206 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPMAG00000005000
Gene Symbol: BRAF
1 Cross references
219 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPMAG00000002198
Gene Symbol: BCL2L1
1 Cross references
576 Possible Orthologues:

Dna (Cytosine-5-)-Methyltransferase 1

Ensembl ID : ENSPMAG00000002625
Gene Symbol: DNMT1
1 Cross references
212 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSPMAG00000007135
Gene Symbol: TOP2A
1 Cross references
207 Possible Orthologues:

Dna Topoisomerase Ia

Ensembl ID : ENSPMAG00000005277
Gene Symbol: TOP1A
1 Cross references
271 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSPMAG00000007141
Gene Symbol: IMPDH1A
1 Cross references
334 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSPMAG00000007311
Gene Symbol: MAPKAPK2
2 Cross references
237 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSPMAG00000009135
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2b

Ensembl ID : ENSPMAG00000004929
Gene Symbol: MKNK2B
1 Cross references
128 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).